Dr Reddys Laboratories (RDY) Operating Margin Growth (3y) (2015 - 2026)

Dr Reddys Laboratories (RDY) Operating Margin Growth (3y) (2015 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin Growth (3y) (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 1,673.00
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -37.00
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -1,442.00
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 13,036.00
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 5,091.00
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 5,310.00
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -11,841.00
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -698.00
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 2,466.00
10 Dr Reddys Laboratories 122.03 Mn -51.98 Mn 368.55 Mn -2,464.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -2,464.00
Dec 31, 2025 -337.00
Jun 30, 2025 -514.00
Mar 31, 2025 -265.00
Dec 31, 2024 1,963.00
Sep 30, 2024 449.00
Jun 30, 2024 238.00
Mar 31, 2024 770.00
Dec 31, 2023 1,198.00
Sep 30, 2023 2,152.00
Jun 30, 2023 898.00
Mar 31, 2023 784.00
Dec 31, 2022 3,308.00
Sep 30, 2022 3,893.00
Jun 30, 2022 1,029.00
Mar 31, 2022 281.00
Dec 31, 2021 -1,062.00
Sep 30, 2021 250.00
Jun 30, 2021 761.00
Mar 31, 2021 56.00